This highlights the likely reason for the downregulation of RPL5 resulting in poorer prognosis for RT patients but not the reason for the upregulation of RPL5 resulting in poorer prognosis for both ALL and AML patients. Here, RPL5 is linked to acute myeloid leukemia.